| Company Name: |
BePharm Ltd |
| Tel: |
400-685-9117 |
| Email: |
market@bepharm.com |
N-[1-[(2R,3R,4S)-4-[Bis(4-methoxyphenyl)phenylmethoxy]tetrahydro-3-hydroxy-2-furanyl]-1,2-dihydro-2-oxo-4-pyrimidinyl]-benzamide manufacturers
|
| | N-[1-[(2R,3R,4S)-4-[Bis(4-methoxyphenyl)phenylmethoxy]tetrahydro-3-hydroxy-2-furanyl]-1,2-dihydro-2-oxo-4-pyrimidinyl]-benzamide Basic information |
| Product Name: | N-[1-[(2R,3R,4S)-4-[Bis(4-methoxyphenyl)phenylmethoxy]tetrahydro-3-hydroxy-2-furanyl]-1,2-dihydro-2-oxo-4-pyrimidinyl]-benzamide | | Synonyms: | N-[1-[(2R,3R,4S)-4-[Bis(4-methoxyphenyl)phenylmethoxy]tetrahydro-3-hydroxy-2-furanyl]-1,2-dihydro-2-oxo-4-pyrimidinyl]-benzamide;N-(1-(4-(Bis(4-methoxyphenyl)(phenyl)methoxy)-3-hydroxytetrahydrofuran-2-yl)-2-oxo-1,2-dihydropyrimidin-4-yl)benzamide;3'-O-DMT-N-Bz-C-TNA;N-(1-((2R,3R,4S)-4-(Bis(4-methoxyphenyl)(phenyl)methoxy)-3-hydroxytetrahydrofuran-2-yl)-2-oxo-1,2-dihydropyrimidin-4-yl)benzamide;Benzamide, N-[1-[(2R,3R,4S)-4-[bis(4-methoxyphenyl)phenylmethoxy]tetrahydro-3-hydroxy-2-furanyl]-1,2-dihydro-2-oxo-4-pyrimidinyl]-;N4-BENZOYL-1-{3`-O-[(4``,4```-DIMETHOXYTRIPHENYL)METHYL]--L -THREOFURANOSYLCYTOSINE;1-[3’-O-[(4,4’-dimethoxytriphenyl)methyl]-a-L-threofuranosyl]-N4-benzoylcytosine | | CAS: | 325683-91-8 | | MF: | C36H33N3O7 | | MW: | 619.66 | | EINECS: | | | Product Categories: | | | Mol File: | 325683-91-8.mol | ![N-[1-[(2R,3R,4S)-4-[Bis(4-methoxyphenyl)phenylmethoxy]tetrahydro-3-hydroxy-2-furanyl]-1,2-dihydro-2-oxo-4-pyrimidinyl]-benzamide Structure](CAS/20150408/GIF/325683-91-8.gif) |
| | N-[1-[(2R,3R,4S)-4-[Bis(4-methoxyphenyl)phenylmethoxy]tetrahydro-3-hydroxy-2-furanyl]-1,2-dihydro-2-oxo-4-pyrimidinyl]-benzamide Chemical Properties |
| density | 1.28±0.1 g/cm3 (20 ºC 760 Torr) | | pka | 8.603±0.20(predicted) |
| | N-[1-[(2R,3R,4S)-4-[Bis(4-methoxyphenyl)phenylmethoxy]tetrahydro-3-hydroxy-2-furanyl]-1,2-dihydro-2-oxo-4-pyrimidinyl]-benzamide Usage And Synthesis |
| Uses | 1-[3’-O-[(4,4’-Dimethoxytriphenyl)methyl]-a-L-threofuranosyl]-N4-benzoylcytosine is a cytidine analog. Cytidine analogs have a mechanism of inhibiting DNA methyltransferases (such as Zebularine, HY-13420), and have potential anti-metabolic and anti-tumor activities[1]. | | References | [1] Gowher H, et al. Mechanism of inhibition of DNA methyltransferases by cytidine analogs in cancer therapy. Cancer Biol Ther. 2004 Nov;3(11):1062-8. DOI:10.4161/cbt.3.11.1308 |
| | N-[1-[(2R,3R,4S)-4-[Bis(4-methoxyphenyl)phenylmethoxy]tetrahydro-3-hydroxy-2-furanyl]-1,2-dihydro-2-oxo-4-pyrimidinyl]-benzamide Preparation Products And Raw materials |
|